The purpose of this paper was to determine the effects of three different pathogen reduction treatments on levels of coagulation factors and coagulation test results in plasma.
Paired analysis of plasma proteins and coagulant capacity after treatment with three methods of pathogen reduction.
Coene J, Devreese K, Sabot B, Feys HB, Vandekerckhove P, Compernolle V
Purpose
Conclusion
Prior to pathogen reduction, levels of all analytes were comparable between treatment groups. Methylene blue (MB), riboflavin (RF) and Amotasalen (AS) treatments reduced levels of fibrinogen, factors (F) II, V, VIII, IX, and XI, Protein C and Protein S and increased prothrombin time (PT) and activated partial thromboplastin time (APTT), but antithrombin was only reduced in RF- and AS-treated specimens, and changes in thrombin generation (TG) depended on treatment. Endogenous thrombin potential (ETP) declined with all treatments while peak thrombin declined in RF- and AS-treated specimens and increased in MB-treated specimens. Lag time and time to peak were shortened by MB and AS treatments but prolonged after RF treatments. The reductions in fibrinogen, FII, FV, FVIII, FIX, FXI and Protein C and changes in PT, APTT, lag time, peak thrombin and ETP were largest for RF-treated specimens.
Studies (1)
Purpose
Summary of Findings
Biospecimens
FluidPlasmaPreservation Types
FrozenDiagnoses
Not specifiedPlatforms
GlycoproteinFlow cytometryGlycoproteinColorimetric assayProteinHematology/ auto analyzerProteinImmunoassayProteinColorimetric assayMorphologyHematology/ auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Aliquot size/volume 254 mL530 mLBiospecimen Aliquots and Components Blood processing method AmotasalenMethylene blueRiboflavinUntreated